Stock Market Reviews

Read and share opinions on ABUS (Arbutus Biopharma Corporation) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock m

Latest News

• Arbutus Announces Four Abstracts Accepted for Presentation at AASLD - The Liver Meeting® 2025
  Oct 7, 2025
• Are Medical Stocks Lagging Arbutus Biopharma (ABUS) This Year?
  Oct 3, 2025
• Is Arbutus Biopharma (ABUS) Stock Outpacing Its Medical Peers This Year?
  Sep 1, 2025
• Is Aquestive Therapeutics (AQST) Stock Outpacing Its Medical Peers This Year?
  Aug 14, 2025
• Arbutus Biopharma (ABUS) Beats Q2 Earnings and Revenue Estimates
  Aug 6, 2025
• Arbutus: Q2 Earnings Snapshot
  Aug 6, 2025
• Arbutus Reports Second Quarter 2025 Financial Results and Provides Corporate Update
  Aug 6, 2025
• Arbutus Reacquires Greater China Rights to Imdusiran and Announces Scientific Advisory Board with Late-Stage Clinical Focus
  Jun 25, 2025
• Arbutus Biopharma (ABUS) Reports Q1 Loss, Tops Revenue Estimates
  May 14, 2025
• Arbutus: Q1 Earnings Snapshot
  May 14, 2025
• Is Editas Medicine (EDIT) Stock Outpacing Its Medical Peers This Year?
  May 13, 2025
• Arbutus Presents Clinical Trial Data from its Two HBV Assets, Imdusiran and AB-101, at the European Association for the Study of the Liver (EASL) Congress 2025
  May 7, 2025
• Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year?
  Apr 25, 2025
• Will Arbutus Biopharma (ABUS) Report Negative Q1 Earnings? What You Should Know
  Apr 24, 2025
• Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025
  Apr 23, 2025
• All You Need to Know About Arbutus (ABUS) Rating Upgrade to Buy
  Mar 31, 2025
• Is Arbutus Biopharma (ABUS) Outperforming Other Medical Stocks This Year?
  Mar 31, 2025